© Copyright 2012 Chemical Biology Ventures Limited. All Rights Reserved. Registered in England & Wales number 7968150. Registered office: 30 Upper High Street, Thame, Oxfordshire, OX9 3EZ. Address for correspondence: 123 Alexander Close, Abingdon, Oxfordshire, OX14 1XD


Chemical Biology News

Welcome to Chemical Biology Ventures News


CBV updates & relevant chemical biology papers, news & comments will be posted

By Lloyd Czaplewski, Nov 21 2012 08:22AM

Chemical Biology Ventures successfully completed an assignment to review preclinical study reports, to provide a publication strategy and to write the first full paper describing the detailed characterisation of a preclinical compound. The paper was accepted by a leading high impact Journal.

With Company downsizing and staff turnover, effectively managing legacy data from lab books and study reports can be a real problem. Chemical Biology Ventures provided an independent review of the information, a clear path to high value publications that will increase community awareness of the attributes of the compounds and will help engage with key opinion leaders as the programme enters clinical evaluation.

RSS Feed

Chemical Biology Ventures News